PreveCeutical Medical Inc. (CSE:PREV)
Canada · Delayed Price · Currency is CAD 0.0250
0.00 (0.00%)
Aug 28, 2026, 9:30 AM EST
PreveCeutical Medical Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.04 | 0.01 | 0.06 | 0 | 0.01 | 0.02 |
Cash & Short-Term Investments | 0.04 | 0.01 | 0.06 | 0 | 0.01 | 0.02 |
Cash Growth | 737.09% | -82.69% | 4029.82% | -74.54% | -64.99% | -89.73% |
Other Receivables | 0.47 | 0.02 | 0.03 | 0.01 | 0.02 | 0.05 |
Receivables | 1.16 | 0.02 | 0.03 | 0.01 | 0.02 | 0.05 |
Prepaid Expenses | 0.05 | 0.06 | 0.03 | 0.06 | 0.04 | 0.01 |
Other Current Assets | - | 0.99 | - | - | - | - |
Total Current Assets | 1.24 | 1.08 | 0.12 | 0.06 | 0.06 | 0.08 |
Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 |
Long-Term Investments | 0.05 | 0.22 | - | - | - | - |
Other Intangible Assets | 0.21 | 0.15 | 0.11 | 0.12 | 0.12 | 0.08 |
Total Assets | 1.51 | 1.45 | 0.23 | 0.18 | 0.19 | 0.16 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2.78 | 0.64 | 0.91 | 0.58 | 0.37 | 0.38 |
Accrued Expenses | - | 1.8 | 1.49 | 1.49 | 1.16 | 0.95 |
Short-Term Debt | 4.77 | 4.61 | 4.4 | 3.83 | 3.23 | 1.25 |
Current Portion of Long-Term Debt | 0.07 | 0.07 | - | 0.06 | 0.06 | - |
Total Current Liabilities | 7.62 | 7.12 | 6.8 | 5.96 | 4.82 | 2.59 |
Long-Term Debt | - | - | 0.06 | - | - | 1.68 |
Other Long-Term Liabilities | 0.57 | 0.57 | - | - | - | - |
Total Liabilities | 8.2 | 7.69 | 6.86 | 5.96 | 4.82 | 4.27 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 21.58 | 21.22 | 19.59 | 19.31 | 19.31 | 18.56 |
Retained Earnings | -32.74 | -31.66 | -29.56 | -28.41 | -27.26 | -28.53 |
Comprehensive Income & Other | 4.47 | 4.19 | 3.33 | 3.32 | 3.32 | 5.86 |
Shareholders' Equity | -6.69 | -6.24 | -6.64 | -5.78 | -4.64 | -4.1 |
Total Liabilities & Equity | 1.51 | 1.45 | 0.23 | 0.18 | 0.19 | 0.16 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 4.84 | 4.68 | 4.46 | 3.89 | 3.29 | 2.93 |
Net Cash (Debt) | -4.81 | -4.67 | -4.4 | -3.89 | -3.29 | -2.91 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Filing Date Shares Outstanding | 602.97 | 598.19 | 565.37 | 539.9 | 535.3 | 523.3 |
Total Common Shares Outstanding | 602.97 | 598.19 | 543.7 | 535.3 | 535.3 | 511.7 |
Working Capital | -6.38 | -6.04 | -6.68 | -5.9 | -4.76 | -2.51 |
Book Value Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Tangible Book Value | -6.9 | -6.4 | -6.74 | -5.89 | -4.76 | -4.18 |
Tangible Book Value Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Machinery | - | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |